197 filings
Page 3 of 10
8-K/A
qssz701 hu1g
30 Jul 21
Financial Statements and Exhibits
11:09am
8-K
gro9qzlubve
28 Jul 21
Cytocom Inc. Announces Completed Merger with Cleveland BioLabs
8:30am
8-K
qv3ly75frxt6
6 Jul 21
Departure of Directors or Certain Officers
5:01pm
8-K
h8ytf
23 Feb 21
Cleveland BioLabs, Inc. Announces $14 Million Registered Direct Offering of Common Stock
5:30pm
8-K
qucymr9hicp4b56x3f
19 Feb 21
Results of Operations and Financial Condition
8:52am
8-K
r3zxksv11d zx8l0
17 Feb 21
Other Events
4:18pm
8-K
oeaqj7w1
8 Jan 21
Regulation FD Disclosure
5:22pm
8-K
w1aeoaj2gom5cd
21 Dec 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
wdnj0xxh9 pt
28 Oct 20
Other Events
5:24pm
8-K
dmwqfxk
21 Oct 20
Cytocom, Inc. Issues Shareholder Letter
4:10pm
8-K
2xdjboeei8lj 7wsudz
19 Oct 20
Cytocom and Cleveland BioLabs Announce Definitive Merger Agreement
4:15pm
8-K
9icd86l524qud 6abk
13 Oct 20
Departure of Directors or Certain Officers
8:30am
8-K
35y44axty
24 Aug 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:46am
8-K
pb2e 8my34453jzdghb
14 Aug 20
Departure of Directors or Certain Officers
8:45am
8-K
bfga2syrztp9y0
31 Jul 20
Entry into a Material Definitive Agreement
5:15pm
8-K
hscpyzwypk 47
3 Jun 20
Cleveland Biolabs Announces $3.175 Million Registered Direct Offering Priced At-the-market Under Nasdaq Rules
4:06pm
8-K
uzbhug2bmahmm
15 May 20
CLEVELAND BIOLABS REPORTS First Quarter 2020 FINANCIAL RESULTS AND DEVELOPMENT PROGRESS
9:00am
8-K
jxfbp
4 May 20
Other Events
8:01am
8-K
epmc93wstaxzt7ea1oc
24 Feb 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:06pm
8-K
ckfegej6lme4 71m6zj
18 Dec 19
Departure of Directors or Certain Officers
5:00pm